AustralianSuper Pty Ltd Raises Stock Holdings in HCA Healthcare, Inc. $HCA

AustralianSuper Pty Ltd grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 164.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,191 shares of the company’s stock after purchasing an additional 29,341 shares during the quarter. AustralianSuper Pty Ltd’s holdings in HCA Healthcare were worth $20,113,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in HCA. Clearstead Trust LLC grew its position in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the period. Harbor Capital Advisors Inc. increased its position in HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $40,000. Compound Global Advisors LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at about $44,000. Finally, True Wealth Design LLC increased its stake in shares of HCA Healthcare by 179.5% in the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after purchasing an additional 70 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $541.77 on Wednesday. The company has a market capitalization of $121.15 billion, a P/E ratio of 19.09, a P/E/G ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a 52-week low of $310.18 and a 52-week high of $552.90. The company has a fifty day moving average of $496.58 and a 200-day moving average of $462.93.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Jefferies Financial Group lifted their price objective on shares of HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Mizuho boosted their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Finally, Oppenheimer raised their price target on shares of HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $534.50.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,214 shares of company stock worth $7,797,595 in the last 90 days. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.